David A Pierce's insider trading at Boston Scientific
SEC Form 4 filings for Pierce David A, 300 Boston Scientific Way, Marlborough, MA 01752, USA

Insider trading of David A Pierce, a SVP,Pres Urology,Pelvic Health at BSX Boston Scientific Corporation

Most recently David A Pierce sold 8,763 shares worth $243,085.62 on 11 January 2018.

Date
#
Company
Insider Title
Trans.
Transaction
Shares Price per share Total price Shares after Source
2018-01-11 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Sale 8,763 $27.74 $243,085.62
2018-01-11
24,201 SEC insider form 4
2018-01-09 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 5,152 $7.41 $38,176.32
2018-01-09
38,116 SEC insider form 4
2018-01-01 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 13,341 $0.00 $0.00
2018-01-01
37,542 SEC insider form 4
2017-06-09 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 13,562 $11.38 $154,335.56
2017-06-09
37,763 SEC insider form 4
2017-06-01 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 2,972 $0.00 $0.00
2017-06-01
28,572 SEC insider form 4
2017-04-26 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 10,250 $7.39 $75,747.50
2017-04-26
35,850 SEC insider form 4
2017-03-03 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Sale 25,012 $25.01 $625,550.12
2017-03-03
25,600 SEC insider form 4
2017-02-28 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 4,398 $0.00 $0.00
2017-02-28
64,794 SEC insider form 4
2017-02-27 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Sale 3,417 $24.84 $84,878.28
2017-02-27
29,816 SEC insider form 4
2017-02-24 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 3,058 $0.00 $0.00
2017-02-24
32,075 SEC insider form 4
2017-02-23 David A Pierce
SVP,Pres Urology,Pelvic Health
SVP,Pres Urology,Pelvic Health Option exercise 2,452 $0.00 $0.00
2017-02-23
29,813 SEC insider form 4
Boston Scientific Corporation logo

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

  • Boston Scientific Corporation, 300 Boston Scientific Way, Marlborough 01752, United States
  • bostonscientific.com
  • 508-683-4000
Messenger